Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1434501000168113 | Naropin 0.2% (ropivacaine hydrochloride monohydrate 40 mg / 20 mL) injection solution, 5 x 20 mL ampoules (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1434511000168111 | Naropin 0.2% 40 mg/20 mL injection solution, 5 x 20 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naropin 0.2% 40 mg/20 mL injection solution, 5 x 20 mL ampoules | Is a | containered trade product pack | false | Inferred relationship | Some | ||
| Naropin 0.2% 40 mg/20 mL injection solution, 5 x 20 mL ampoules | Is a | Naropin 0.2% 40 mg/20 mL injection solution, 5 x 20 mL ampoules | false | Inferred relationship | Some | ||
| Naropin 0.2% 40 mg/20 mL injection solution, 5 x 20 mL ampoules | has container type | ampoule | false | Inferred relationship | Some | ||
| Naropin 0.2% 40 mg/20 mL injection solution, 5 x 20 mL ampoules | has TP | Naropin 0.2% | false | Inferred relationship | Some | ||
| Naropin 0.2% 40 mg/20 mL injection solution, 5 x 20 mL ampoules | has TPUU | Naropin 0.2% 40 mg/20 mL injection solution, 20 mL ampoule | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian dialect reference set
Concept inactivation indicator reference set
Description inactivation indicator reference set
REPLACED BY association reference set
FHIR